Background: A number of case-control studies have evaluated associations between the X-ray cross complementary group 1 protein (XRCC1) gene rs1799782 (Arg194Trp), rs25487 (Arg399Gln) and rs25489 (Arg280His) polymorphisms and thyroid cancer (TC) risk, but the results remain inconclusive. Materials and Methods: A systematic literature search was performed using PubMed and Google Scholar Search. According to defined criteria data were extracted and pooled odds ratios with 95% confidence intervals were calculated under five genetic models. Results: A total of 8 studies with 1,672 cases and 2,805 controls for the rs1799782 polymorphism, 14 studies with 2,506 cases and 5,180 controls for the rs25487 polymorphism, and 11 studies with 2,197 cases and 4,761 controls for the rs25489 polymorphism were included in this meta-analysis. Overall, there was a statistical association between XRCC1 rs1799782 polymorphism and TC risk with the homozygote genetic model (TT vs. CC: OR = 1.815, 95% CI = 1.115-2.953, p= 0.016) and the recessive genetic model (TT vs. TC+CC: OR = 1.854, 95% CI = 1.433-2.399, p= <0.001). In the subgroup analysis by ethnicity, significantly increased TC risk was observed only in Asians under the recessive model (TT vs. TC+CC: OR = 1.816, 95% CI = 1.398-2.358, p= <0.001). In addition, there was no positive association between XRCC1 rs25487 and rs25489 polymorphisms and risk of TC. However, there was a significant association between XRCC1 rs25487 polymorphism risk of TC among Caucasians with allele genetic comparison (A vs. G: OR= 0.882, 95% CI = 0.794-0.979, p= 0.136) and dominant genetic comparison (AA+AG vs. GG: OR=0.838, 95% CI = 0.728-0.965, p= 0.014). Conclusions: The results of our meta-analysis suggest an increased risk of TC with the XRCC1 rs1799782 and rs25487 polymorphisms. However, the XRCC1 rs25489 polymorphism appeared to be without influence.
Introduction
Thyroid cancer (TC) is the most common malignancy of the endocrine system in human, which accounts for nearly 3.8% of newly diagnosed cancers annually (Visciano et al., 2015; SEER, 2016) . According to the last reports, the incidence of TC is the third fastest rising cancer diagnosis in the USA, which its incidence is rapidly increasing from 7.6 to 14.9 per 100,000 in a decade (between 2000 and 2012) (De Lellis, 2004; Morris et al., 2013) .
Thyroid malignancies are categorized into several subtypes including follicular (FTC), papillary (PTC), medullary (MTC), undifferentiated, Hurthle cell and a subgroup of rare morphologies such as mucoepidermoid, oncocytic carcinomas and squamous (DeLellis, 2004; Schneider et al., 2013) . In addition, TC could be categorized as either sporadic or familial, which only 5-7% of TC cases are familial (Nagy and Ringel, 2015; Haugen et al. 2016) . According to the studies, a TC risk factors is very complex, simply is anything that causes to increase the susceptibility of TC. However, a combination of genetic and environmental factors (predominantly including: age, gender, ethnicity, family history, radiation exposure and iodine intake) likely contributes to the development of TC. The underlying genetics cause of TC varies based on its histology. The genetic cause of MTC is well identified. Hereditary MTC is caused by mutations in the RET proto-oncogene that cause multiple endocrine neoplasia 2A (MEN2A) syndrome characterized by MTC, parathyroid hyperplasia and pheochromocytoma, and multiple endocrine neoplasia 2A (MEN2B) syndrome characterized by MTC, pheochromocytoma, mucosal neuromas, and tall, asthenic habitus. However, the genetic causes of familial non-medullary thyroid carcinoma (FNMTC) are less understood (Morrison et al., 2009; Nagy and Ringel, 2015) .
Associations between X-ray cross complementary group 1 protein (XRCC1) gene polymorphisms and multiple cancers have already been reported. Three major polymorphisms of the XRCC1 gene have been identified at codon 194 (rs1799782, C > T substitution at position 26304, exon 6, Arg to Trp), at codon 280 (rs25489, C > T substitution at position 43552260, exon 9, Arg to His), and at codon 399 (rs25487, G > A substitution at position 28152, exon 10, Arg to Gln) (Garcia et al. 2011; Santos et al. 2012; and Halkova et al. 2016) . Recently, several studies have demonstrated that the polymorphism of XRCC1 gene was associated with the TC. However, these results were inconsistent. And for the relatively small sample size of the published studies, it is necessary to accumulate data from different studies to provide evidence on the association of XRCC1 gene polymorphisms with risk of TC. Moreover, in recent years more studies with large sample have been published. Therefore, we performed a meta-analysis to further estimate the overall risk of TC caused by the XRCC1 rs1799782 (Arg194Trp), rs25487 (Arg399Gln) and rs25489 (Arg280His) polymorphisms in patients.
Materials and Methods

Literature search strategy
The databases include Pubmed, Google Scholar, MEDLINE, ISI Web of Science and SCOPUS database up to January 5th, 2017 to identify all relevant articles on the subject. We have used various combinations of keywords to screen for potentially relevant studies, including "Thyroid cancer"; "DNA repair gene", "XRCC1" or "XRCC1 DNA repair protein"; "Genetic polymorphism" or "single nucleotide polymorphism" or "polymorphism" or "SNP" or "mutation" or "variation", with restricted to English language and only published studies with full-text articles available. All eligible studies were retrieved, then we also manually searched the references of included studies to identify more potentially relevant articles.
Including and Excluding Criteria
Studies included to the meta-analysis had to be consistent with the following criteria: (1) only studied on human; (2) only the case-control studies and cohorts, (3) studies have evaluated the XRCC1 rs1799782 (Arg194Trp), rs25487 (Arg399Gln) and rs25489 (Arg280His) polymorphisms and TC risk, and (4) sufficient published data (specially frequency of the genotypes) for estimating an odds ratio (OR) with 95% confidence interval (CI). Major reasons for exclusion of studies were as follows: (1) not on human, (2) not cancer research (3) only on patients, (4) duplicate of previous papers, and (5) have not sufficient data about frequency of genotypes.
Data extraction
Two authors carefully and independently were extracted the data from all eligible publications using a structured table. The following items were considered: first author's name, year of publication, ethnicity, and country of study population, number of cases and controls, genotype number in cases and controls, and p-value for Hardy-Weinberg equilibrium (HWE). The subject's ethnicities were categorized as Caucasian, Asian, or African. Disagreements were resolved in consultation with the third reviewer.
Statistical Analysis
An ethical approval was not necessary needed as this is a meta-analysis based on previous studies. The strength of association between XCCR1 gene polymorphism and TC risk was tested by odds ratios (ORs) with 95% confidence intervals (CIs) using Z test. The summarized ORs were performed for rs1799782 (allele model: T vs The Chi-squared Q-test and I2 statistics were used to identify the heterogeneity among included publications (Zintzaras et al., 2005) . The fixed-effects model (the Mantel-Haenszel method) is used when the effects are assumed to be homogenous (P ≥ 0.1 or I2 <50%). Otherwise, the random effects model (the DerSimonian and Laird method) is used when they are heterogeneous (P < 0.1 or I2 ≥ 50%). Subgroup analyses by ethnicity was also performed to identify the substantial heterogeneity. Additionally, the effect of each single study on the overall estimate was determined by application of oneway sensitivity analysis. The sensitivity analysis was performed by omitting 1 study at a time. To examine the potential publication bias in the meta analysis, Begg's funnel plot and Egger's test were used; P<0.05 indicated that the result was statistically significant (Song et al., 1998; Peters et al., 2006) . All the statistical analyses were performed by comprehensive meta-analysis (CMA) V2.0 software (Biostat, USA). Two-sided P values < 0.05 were considered statistically significant.
Results
Characteristics of the published studies
Initially, we have identified 39 publications, among which 18 irrelevant articles were excluded. Thus, 21 publications were eligible. Among these publications, six publications were excluded because they were review articles and other polymorphisms of XRCC1 gene, and also one paper was excluded because of it subject overlapped with other included study. As seen in Tables  1-3, 14 case-control studies were selected in the final meta-analysis, including 8 case-control studies with a total of 1,672 cases and 2,805 controls concerning the XRCC1 rs1799782 polymorphism (Table 1) , 14 studies with a total of 2,506 cases and 5,180 controls for XRCC1 rs25487 polymorphism (Table 2) , and 11 studies with a total of 2,197 cases and 4,761 controls for XRCC1 rs25489 polymorphism (Table 3) (Sigurdsson et al., 2009; Akulevich et al., 2009; Ho et al., 2009; Garcia et al., 2011; Santos et al. 2012; and Halkova et al. 2016 ) and 7 studies of Asian descendants (Zhu et al., 2004; Chiang et al., 2008; Siraj et al. 2008; Esfahani et al. 2011; Ryu et al., 2011; Wang et al., 2015 and Yan et al., 2015) . The populations came from different countries, including China, India, Iran, Brazil, Russia, Belarus, Korea, Spain, Portugal, Czech and Kingdom of Saudi Arabia (KSA). Genotype distributions in the controls of 3 publication (predominantly, the publication of Wang et al., 2015) were not in agreement with HWE. Table 4 listed the main results of the meta-analysis of XRCC1 rs1799782 (Arg194Trp) polymorphism and TC risk ( Figure 1A ). When all the eligible studies were pooled into the meta-analysis of XRCC1 Arg194Trp polymorphism, significantly increased risk of TC was observed in homozygote (TT vs. CC: OR = 1.815, 95% CI = 1.115-2.953, p= 0.016) and recessive (TT vs. TC+CC: OR = 1.854, 95% CI = 1.433-2.399, p= <0.001). In the subgroup analysis by ethnicity, significantly increased TC risk was observed in Asians only under recessive model (TT vs. TC+CC: OR = 1.816, 95% CI = 1.398-2.358, p= <0.001) by using fixed-effect model, but not among Caucasians.
Meta-analysis XRCC1 rs1799782 Polymorphism
XRCC1 rs25487 Polymorphism
The main results of XRCC1 rs25487 (Arg399Gln) Table 2 ), but not among Asians.
XRCC1 rs25489 Polymorphism
As shown in Table 6 , no significant association was detected between the XRCC1 rs25489 (Arg280His) polymorphism and TC risk under all five genetic models 
Test of heterogeneity
For XRCC1 rs1799782 (Arg194Trp) polymorphism, when we have pooled the data a significant heterogeneity observed in heterozygote (I 2 =64.0%, P H =0.007), homozygote (I 2 =51.90%, P H =0.042) and dominant (I 2 =77.9%, P H =0.007) genetic models ( .2%, P H =<0.001). Therefore, the observed heterogeneity between the included studies might be due to the ethnicities.
Sensitivity Analysis
We have performed sensitivity analysis by omitting Table 6 . Meta-Analysis of the Association of XRCC1 rs25489 Polymorphism with TC.
1 study at a time, but the estimate of overall effect did not change noticeably. In addition, when we excluded the studies not in agreement with HWE, the statistical significance of the results not changed.
Publication Bias
We have used Begg's funnel plot and Egger's test to assess the publication bias. However, as show in Figure  2A , 2B, the funnel plots did not reveal any obvious asymmetry in all genotypes in overall population, and the results of Begg's test revealed no publication bias (P>0.05).
Discussion
The XRCC1 plays an important role in the base excision repair (BER) pathway and interacts with DNA polymerase Beta (POLB), Poly ADP ribose Polymerase (PARP) and DNA ligase III (Zhang et al., 2006) . The XRCC1gene (Gene ID 37414; OMIM 21171001 and 21174504), is 33 kb long and located at chromosome 19q13.3, consists of 17 exons, and encodes a 2.2 kb transcript, which produces an enzyme called X-ray cross-complementing group 1 that is involved in base excision repair pathway (Wang et al., 2015) . XRCC1 polymorphisms disrupt the interaction of XRCC1 with other enzymatic proteins and consequently overwhelm DNA repair capacity, which leads to genetic instability and carcinogenesis (Forat Yazdi et al., 2014) .
In the present meta-analysis, we have evaluated the association between three most common XRCC1 gene polymorphisms including rs1799782 (Arg194Trp), rs25487 (Arg399Gln) and rs25489 (Arg280His) polymorphisms and risk of TC. To the best of our knowledge, this is the most comprehensive meta-analysis of the relationship between XRCC1 polymorphisms and the risk of TC. We have found the absence of rs25487 (Arg399Gln) and rs25489 (Arg280His) polymorphisms are significantly associated with an increased risk of TC, while the rs1799782 (Arg194Trp) polymorphism significantly associated with development of TC in the overall analysis. However, there was a significant association between XRCC1 rs25487 polymorphism risk of TC among Caucasians under allele genetic comparison (A vs. G: OR= 0.882, 95% CI = 0.794-0.979, p= 0.136) and dominant genetic comparison (AA+AG vs. GG: OR=0.838, 95% CI = 0.728-0.965, p= 0.014). Moreover, the T allele of XRCC1 rs1799782 and A allele of XRCC1 rs25487 may be as a marker for increased susceptibility to TC. Similarly, in a meta-analysis Qian et al. have not an association between XRCC1 rs25487 (Arg399Gln) and rs25489 (Arg280His) polymorphisms and TC risk in the overall analysis. However, they have not found such association for third polymorphism with risk of TC, too (Qian et al., 2012) . The contribution of rs1799782 (Arg194Trp) polymorphism in development of TC was identified by Zhao et al. in meta-analysis of five studies, comprising 911 patients and 1476 controls, recently. However, inconsistent with our results, Li et al., (2014) and Wu et al., (2014) in the two different meta-analysis of 8 and 10 studies not found a significant association between TC risk and the three polymorphisms of XRCC1 gene in all genetic Models. Due to the difference in genetic backgrounds and the environment in which the subjects were lived, we have performed a subgroup analysis by ethnicity, however we found a significant association between rs1799782 and rs25487 polymorphism and TC risk in Asians and Caucasians, respectively.
Interestingly, in meta-analysis Yan et al., (2015) based on previous studies quoted that the XRCC1 rs25489 polymorphism is related to different cancers in Asian populations, including gastric cancer, bladder cancer, lung cancer, and colorectal cancer. While, this meta-analysis results and three previous meta-analysis by Qian et al., (2012) Li et al., (2014) and Wu et al., (2014) there was not such association between XRCC1 rs25489 polymorphism and risk of TC. Therefore, it seems the A allele of XRCC1 rs25489 may not be as a marker for increased susceptibility to TC.
To the best of our knowledge, the current meta-analysis made a more convincing and detailed evaluation than the previous meta-analysis did. However, there are some limitations should be also recognized in this meta-analysis. First, the included studies were restricted to just English literature, which might bias the results. Second, severe TC is a multifactorial condition that results from complex interactions between genes and environmental factors such as age, gender, ethnicity, family history, radiation exposure and iodine intake. Therefore, we might fail to receive the true associations when we only considered those three XRCC1 gene polymorphisms, but neglect the role of other genetic, polymorphisms, and environmental factors in TC. Finally, the sample size of subgroup analysis by ethnicity was limited, which may causes to reduce the power of analyses. Therefore, further studies with large sample sizes are required to gain more precise results.
In summary, the results of the meta-analysis suggest an increased risk role of the XRCC1 rs1799782 and rs25487 polymorphisms in TC development. However, there was no association between the XRCC1 rs25489 polymorphisms and TC risk. More studies with a larger sample size is needed to further evaluate the association XRCC1 gene polymorphisms and TC risk.
